These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6119212)

  • 1. Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs.
    Burmeister WE; Reynolds RD; Lee RJ
    Eur J Pharmacol; 1981 Oct; 75(1):7-10. PubMed ID: 6119212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
    Bril A; Slivjak M; DiMartino MJ; Feuerstein GZ; Linee P; Poyser RH; Ruffolo RR; Smith EF
    Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise training during chronic beta blockade in cardiovascular disease.
    Fletcher GF
    Am J Cardiol; 1985 Apr; 55(10):110D-113D. PubMed ID: 2859788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of propranolol on myocardial infarct size with and without coronary artery reperfusion in the dog.
    Reynolds RD; Burmeister WE; Gorczynski RJ; Dickerson DD; Mathews MP; Lee RJ
    Cardiovasc Res; 1981 Jul; 15(7):411-20. PubMed ID: 7307024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
    O'Callaghan WG; Laher MS; McGarry K; O'Brien E; O'Malley K
    Br J Clin Pharmacol; 1983 Oct; 16(4):417-21. PubMed ID: 6138058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial protection with carvedilol.
    Feuerstein GZ; Hamburger SA; Smith EF; Bril A; Ruffolo RR
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S138-41. PubMed ID: 1378142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure.
    Brenner BM; Duchin KL; Ichikawa I; Pfeffer J; Pfeffer M
    Am Heart J; 1984 Oct; 108(4 Pt 2):1144-7. PubMed ID: 6148876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction.
    Wilcox RG; Roland JM; Banks DC; Hampton JR; Mitchell JR
    Br Med J; 1980 Mar; 280(6218):885-8. PubMed ID: 6992916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
    Beaulieu G; Grimes D; Muirhead C; Oshiro G
    Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.
    Wilcox RG; Hampton JR
    Br J Clin Pharmacol; 1982 Jun; 13(6):841-6. PubMed ID: 6124268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective potential of carvedilol.
    Ruffolo RR; Bril A; Feuerstein GZ
    Cardiology; 1993; 82 Suppl 3():24-8. PubMed ID: 8106160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of propranolol, timolol and metoprolol on myocardial infarct size after experimental coronary artery occlusion.
    Vik-Mo H; Maroko PR; Ribeiro LG
    J Am Coll Cardiol; 1984 Oct; 4(4):735-41. PubMed ID: 6481013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
    Patterson E; Lucchesi BR
    Pharmacology; 1984; 28(3):121-9. PubMed ID: 6144114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
    Romakov AIu; Sagirov AM; Desiatnichenko VM; Sobol' IuS; Sumarokov AB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):57-63. PubMed ID: 6139118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic blockade alone does not decrease renal perfusion in black hypertensives.
    Brater DC; Anderson S; Kaplan NM; Ram CV
    J Hypertens; 1984 Feb; 2(1):43-8. PubMed ID: 6152277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
    Pupita F; Ansuini R; Belogi M; Pupita G; Gaggi S
    Int J Clin Pharmacol Res; 1985; 5(6):439-45. PubMed ID: 2869001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing angina with beta blockers.
    Segal BL; Kotler MN; Iskandrian AS
    Geriatrics; 1982 Oct; 37(10):69-72, 76. PubMed ID: 6126421
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
    J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.